Vossen, A R J V <br/><br/>
The anti-inflammatory potency of biologics targeting tumour necrosis factor-α, interleukin (IL)-17A, IL-12/23 and CD20 in hidradenitis suppurativa: an ex vivo study.  [electronic resource] 

 -  The British journal of dermatology  08 2019 
 - 314-323 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2133 
<br/><br/><label>Standard No.: </label>10.1111/bjd.17641  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Inflammatory Agents--pharmacology<br/>Antigens, CD20--immunology<br/>Antimicrobial Cationic Peptides--antagonists & inhibitors<br/>Biological Products--pharmacology<br/>Biopsy<br/>Female<br/>Healthy Volunteers<br/>Hidradenitis Suppurativa--drug therapy<br/>Humans<br/>Interleukin-12 Subunit p40--antagonists & inhibitors<br/>Interleukin-17--antagonists & inhibitors<br/>Male<br/>Middle Aged<br/>Organ Culture Techniques<br/>Prednisolone--pharmacology<br/>Skin--drug effects<br/>Tumor Necrosis Factor-alpha--antagonists & inhibitors